Malaria, that insidious spectre borne on the wings of Anopheles mosquitoes, persists as one of humanity’s most savage pandemics, a stealthy assassin infiltrating bloodstreams and shattering lives across continents. In Nigeria, our nation’s lifeblood pulses with vulnerability. This scourge unfurls a cascade of devastation, weaving economic ruin into the fabric of societies. Healthcare systems groan under the weight, billions are squandered on treatment and hospitalization, while productivity evaporates as fevered labourers, farmers and traders succumb to cycles of illness. Vulnerable populations bear the brunt with heartbreaking ferocity. Children under five are overwhelmed by Plasmodium Falciparum’s toxic onslaught, leading to cerebral malaria’s tragic seizures or relentless anemia, and pregnant women with resultant low birth weight, maternal anemia and stillbirths, perpetuating intergenerational frailty.
Socially, malaria erects invisible barricades. Schools become empty as absenteeism soars, literacy rates plummet and the cycle of ignorance continues. Gender inequity amplifies; women/primary caregivers shoulder disproportionate burdens, delaying empowerment. Healthcare infrastructures buckle: overcrowded wards, depleted drug stocks and exhausted providers, exacerbating outbreaks of co-infections like tuberculosis. Yet, this scourge is not invincible. Prevention forms the bedrock of our defense, empowering communities to strike first against the mosquito menace.
Key strategies include consistent use of insecticide-treated nets for undisturbed sleep, indoor residual spraying to eliminate breeding grounds and prompt environmental management like draining stagnant water and clearing vegetation. Personal protection shines through daily habits, which include applying repellents, wearing long-sleeved clothing at dusk and early screening for household members. For high-risk groups like pregnant women, intermittent preventive treatment, endorsed by NAFDAC and the National Malaria Elimination Programme, drastically reduces cases.
Geneith Pharmaceuticals stands at the forefront as the treatment solution to this malaria pandemic, offering a robust portfolio of effective antimalarials.
Other News
Our flagship products include Camosunate for rapid parasite clearance, the Coatal range and Coatal Soft Gel for convenient oral therapy, Lotexin for reliable treatment and Lever Injection for severe malaria and extreme cases where patients cannot take tablets, providing swift intravenous and intra-muscular action, stabilizing patients and preventing progression to critical stages.
At Geneith Pharmaceuticals, we remain unrelenting in our pursuit of eradicating malaria. Through innovation, accessibility and partnerships with healthcare providers, key opinion leaders and regulatory bodies, we drive demand generation, healthcare professional engagement and community awareness.
On this World Malaria Day, join us in breaking the cycle. Together, we can end malaria’s grip on society!
• Pharm. Abimbola Bowoto, AGM, Marketing, Geneith Pharmaceuticals Ltd.

Follow Us on Google